BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16467413)

  • 21. No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study.
    Smiles AM; Jenny NS; Tang Z; Arnold A; Cushman M; Tracy RP
    Thromb Haemost; 2002 Apr; 87(4):614-21. PubMed ID: 12008943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study.
    Horne BD; Carlquist JF; Muhlestein JB; Nicholas ZP; Anderson JL;
    Am Heart J; 2007 Nov; 154(5):969-75. PubMed ID: 17967605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen genes and myocardial infarction: a haplotype analysis.
    Koch W; Hoppmann P; Biele J; Mueller JC; Schömig A; Kastrati A
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):758-63. PubMed ID: 18202324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population.
    Yang W; Huang W; Su S; Li B; Zhao W; Chen S; Gu D
    Clin Sci (Lond); 2006 Nov; 111(5):333-40. PubMed ID: 16822235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women.
    Mansego ML; Redon J; Marin R; González-Albert V; Martin-Escudero JC; Fabia MJ; Martinez F; Chaves FJ
    J Hypertens; 2008 Feb; 26(2):230-7. PubMed ID: 18192836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration.
    Mannila MN; Eriksson P; Leander K; Wiman B; de Faire U; Hamsten A; Silveira A
    J Intern Med; 2007 Feb; 261(2):138-47. PubMed ID: 17241179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy.
    Tavani A; Bertuzzi M; Gallus S; Negri E; La Vecchia C
    J Clin Epidemiol; 2005 Jul; 58(7):747-50. PubMed ID: 15939229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
    Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
    Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease.
    Horne BD; Camp NJ; Anderson JL; Mower CP; Clarke JL; Kolek MJ; Carlquist JF;
    J Am Coll Cardiol; 2007 May; 49(20):2053-60. PubMed ID: 17512363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
    Koch W; Hoppmann P; Mueller JC; Schömig A; Kastrati A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1114-9. PubMed ID: 16543493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
    Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
    Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.
    Blankenberg S; Godefroy T; Poirier O; Rupprecht HJ; Barbaux S; Bickel C; Nicaud V; Schnabel R; Kee F; Morrison C; Evans A; Lackner KJ; Cambien F; Münzel T; Tiret L;
    Circ Res; 2006 Jul; 99(1):102-8. PubMed ID: 16778130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial protein C receptor polymorphisms and risk of myocardial infarction.
    Medina P; Navarro S; Corral J; Zorio E; Roldán V; Estellés A; Santamaría A; Marín F; Rueda J; Bertina RM; España F;
    Haematologica; 2008 Sep; 93(9):1358-63. PubMed ID: 18757851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of genetic risk for myocardial infarction.
    Yamada Y; Matsuo H; Segawa T; Watanabe S; Kato K; Hibino T; Yokoi K; Ichihara S; Metoki N; Yoshida H; Satoh K; Nozawa Y
    Thromb Haemost; 2006 Aug; 96(2):220-7. PubMed ID: 16894468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.